| Financial Year |
March 31 2023 |
| Monetary Funds |
14,102,264,205.61 |
| Held-for-trading Financial Assets |
217,485,799.74 |
| Notes Receivable |
491,018,487.90 |
| Accounts Receivable |
4,825,944,827.62 |
| Advances to Suppliers |
2,032,475,995.75 |
| Other Receivables |
345,125,333.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,477,597,673.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,151,123.18 |
| Other Current Assets |
1,599,295,927.00 |
| Total Current Assets |
37,564,089,996.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
173,908,489.29 |
| Long-term Equity Investment |
13,164,358,822.12 |
| Investment Properties |
-- |
| Fixed Assetes |
46,579,391,249.68 |
| Under-construction Projects |
3,881,632,283.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,906,359,878.67 |
| R&D expenses |
26,497,425.02 |
| Goodwill |
221,865,586.69 |
| Long-Term Deferred and Prepaid Expenses |
411,574,848.44 |
| Deferred Income Tax Assets |
487,493,888.32 |
| Other Non-Current Assets |
1,383,483,090.66 |
| Sub-Total of Non-Current Assets |
69,668,555,445.20 |
| Total Assets |
107,232,645,442.19 |
| Short-Term Loans |
38,838,674,016.60 |
| Trading Financial liabilities |
51,602,403.70 |
| Notes Payable |
2,246,569,421.16 |
| Accounts Payable |
3,839,104,993.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
152,627,468.22 |
| Taxes Payable |
184,729,398.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
214,779,668.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,610,940,362.02 |
| Other Current Liabilities |
176,994,913.22 |
| Sub-Total of Current Liabilities |
53,778,679,641.91 |
| Long-term Loans |
15,961,990,417.64 |
| Bonds Payable |
4,115,541,533.32 |
| Long-Term Accounts Payable |
1,133,680,128.20 |
| Special Payable |
-- |
| Estimatied Liabilities |
360,508.08 |
| Deferred Income Tax Liabilities |
76,289,769.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,928,200,977.31 |
| Total Liabilities |
75,706,880,619.22 |
| Paid-In Capital(Or Share Stock) |
3,666,296,532.00 |
| Capital Surplus |
9,076,089,785.58 |
| Surplus Reserve |
781,701,619.18 |
| LESS:Treasury Stock |
2,033,507,352.25 |
| Undistributed Profits |
11,806,483,843.30 |
| Minority Stockholder's Interest |
6,931,126,510.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,594,638,312.20 |
| Owner's Equity（Stockholder's Equity） |
31,525,764,822.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
107,232,645,442.19 |
